Astrana Health, Inc. - Common Stock (ASTH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ASTH on Nasdaq
Shares outstanding
50,156,118
Price per share
$22.00
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
29,137,341
Total reported value
$724,380,671
% of total 13F portfolios
0%
Share change
+2,612,522
Value change
+$62,758,426
Number of holders
174
Price from insider filings
$22.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Astrana Health, Inc. - Common Stock (ASTH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% +9.1% $191,646,870 -$6,109,882 6,234,446 -3.1% BlackRock, Inc. 31 Mar 2025
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 11% -10% $188,522,333 -$21,514,803 6,132,802 -10% Allied Physicians of California, a Professional Medical Corporation 15 Feb 2025
VANGUARD GROUP INC 8.4% -12% $105,149,544 -$14,766,714 4,238,192 -12% The Vanguard Group 31 Dec 2025

As of 31 Dec 2025, 174 institutional investors reported holding 29,137,341 shares of Astrana Health, Inc. - Common Stock (ASTH). This represents 58% of the company’s total 50,156,118 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Astrana Health, Inc. - Common Stock (ASTH) together control 49% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 6,157,754 +2.5% 0% $152,773,879
VANGUARD GROUP INC 8.5% 4,238,192 -10% 0% $105,149,543
325 CAPITAL LLC 3.7% 1,839,076 +54% 16% $45,627,476
STATE STREET CORP 3.3% 1,675,516 +6.2% 0% $41,569,552
DIMENSIONAL FUND ADVISORS LP 2.4% 1,215,812 -1.5% 0.01% $30,164,897
FMR LLC 2.1% 1,069,809 -0.55% 0% $26,541,963
GEODE CAPITAL MANAGEMENT, LLC 2% 1,028,168 +1.2% 0% $25,513,406
WELLINGTON MANAGEMENT GROUP LLP 1.5% 738,853 +418% 0% $18,330,943
SteelPeak Wealth, LLC 1.2% 579,937 0% 0.47% $14,388,237
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 549,152 -2.3% 0% $13,624,461
BANK OF AMERICA CORP /DE/ 1% 507,101 +193% 0% $12,581,176
JACOBS LEVY EQUITY MANAGEMENT, INC 0.94% 473,714 -5.4% 0.05% $11,752,844
NorthCrest Asset Manangement, LLC 0.9% 450,465 +0.46% 0.28% $12,342,741
AMERIPRISE FINANCIAL INC 0.87% 437,996 -0.98% 0% $10,866,681
MORGAN STANLEY 0.86% 433,825 -13% 0% $10,763,199
DIAMOND HILL CAPITAL MANAGEMENT INC 0.86% 432,726 +20% 0.06% $10,735,932
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.83% 416,930 -1.1% 0.03% $10,344,033
NORTHERN TRUST CORP 0.8% 402,463 -4.9% 0% $9,985,107
Invesco Ltd. 0.71% 355,216 +46% 0% $8,812,908
ROYCE & ASSOCIATES LP 0.69% 348,331 +34% 0.09% $8,642,092
GOLDMAN SACHS GROUP INC 0.63% 314,691 -0.73% 0% $7,807,484
LPL Financial LLC 0.62% 309,125 +74% 0% $7,669,391
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.61% 305,061 +74124% 0.01% $7,568,000
PRINCIPAL FINANCIAL GROUP INC 0.46% 229,798 +3.1% 0% $5,701,289
Bank of New York Mellon Corp 0.46% 229,664 -6.4% 0% $5,697,970

Institutional Holders of Astrana Health, Inc. - Common Stock (ASTH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 29,137,341 $724,380,671 +$62,758,426 $24.81 174
2025 Q3 26,741,876 $759,044,828 +$22,747,086 $28.35 186
2025 Q2 25,772,189 $641,392,329 -$15,342,979 $24.88 161
2025 Q1 26,257,633 $814,637,036 +$5,862,823 $31.01 168
2024 Q4 26,057,927 $822,017,819 +$3,128,832 $31.53 177
2024 Q3 25,295,709 $1,465,673,353 +$131,700,353 $57.94 186
2024 Q2 23,072,576 $935,815,210 +$22,763,995 $40.56 169
2024 Q1 22,756,494 $955,393,465 +$24,413,741 $41.99 158
2023 Q4 22,178,838 $849,210,903 +$26,256,665 $38.30 141
2023 Q3 21,503,159 $663,623,547 +$22,662,738 $30.85 132
2023 Q2 20,757,071 $656,229,537 +$22,212,849 $31.60 129
2023 Q1 20,034,782 $730,631,066 +$14,461,853 $36.47 131
2022 Q4 19,704,382 $583,144,207 -$13,404,604 $29.59 129
2022 Q3 19,814,272 $772,607,625 +$70,014,740 $39.00 148
2022 Q2 17,767,757 $685,808,256 +$18,274,263 $38.59 126
2022 Q1 17,609,470 $853,298,644 +$10,418,988 $48.47 129
2021 Q4 17,108,614 $1,256,730,970 +$26,349,379 $73.48 140
2021 Q3 16,644,270 $1,516,521,911 +$595,571,146 $91.05 137
2021 Q2 10,256,705 $644,299,364 +$260,959,544 $62.81 102
2021 Q1 6,359,542 $172,275,211 +$32,027,527 $27.09 75
2020 Q4 5,211,206 $95,222,607 +$2,906,278 $18.27 60
2020 Q3 5,058,422 $90,682,749 +$15,496,005 $17.94 62
2020 Q2 4,195,952 $69,229,389 +$12,105,432 $16.50 49
2020 Q1 3,507,141 $45,315,795 -$1,124,491 $12.92 49
2019 Q4 3,560,356 $65,544,872 -$36,902,879 $18.41 54
2019 Q3 5,569,591 $98,135,067 +$47,954,977 $17.62 46
2019 Q2 2,846,110 $47,557,190 +$8,339,757 $16.71 36
2019 Q1 2,387,347 $43,737,062 -$549,177 $18.33 37
2018 Q4 2,407,330 $47,779,685 +$851,599 $19.85 39
2018 Q3 2,283,686 $50,402,877 -$7,479,217 $22.07 36
2018 Q2 2,611,128 $67,524,947 +$58,395,475 $25.86 32
2018 Q1 541,971 $8,644,000 +$7,424,160 $15.95 13
2017 Q4 50,403 $1,209,000 +$1,209,000 $23.97 6